Usana Health Sciences (USNA) EBT Margin (2010 - 2026)

Usana Health Sciences (USNA) has reported EBT Margin for 17 consecutive years, with 8.46% the latest figure, recorded in Q3 2026.

• On a quarterly basis, EBT Margin fell 1644.0% year-over-year to 8.46% in Q3 2026; TTM through Jul 2026 was 0.28%, a 691.0% decrease from a year earlier, with the FY2026 full-year figure at 4.49%, down 445.0% from the prior year.
• EBT Margin was 8.46% for Q3 2026 at Usana Health Sciences, down from 6.18% in the prior quarter.
• Over five years, EBT Margin peaked at 13.03% in Q1 2022 and troughed at 8.46% in Q3 2026.
• A 5-year average of 7.96% and a median of 9.62% in 2023 frame the typical range for EBT Margin.
• Across the five-year window, EBT Margin jumped 203 bps in 2023 and slumped 1644 bps in 2026, its largest moves.
• Over 5 years, EBT Margin stood at 10.0% in 2022, then gained by 20 bps to 12.04% in 2023, then slumped by 59 bps to 4.88% in 2024, then slumped by 83 bps to 0.84% in 2025, then tumbled by 1108 bps to 8.46% in 2026.
• The last three EBT Margin figures came in at 8.46% (Q3 2026), 6.18% (Q2 2026), and 1.85% (Q1 2026), per Business Quant data.